[1] Denny JC,Collins FS. Precision medicine in 2030-seven ways to transform healthcare[J].Cell,2021,184(6):1415-1419.
[2] Fedyuk V, Erez N, Furth N, et al. Multiplexed, single-molecule,epigenetic analysis of
plasma-isolated nucleosomes for cancer diagnostics[J].Nat Biotechnol,2023,41(2):212-221.
[3] Ye Y. Unleashing the power of
big data to guide precision medicine in China[J].Nature,2022,606(7916):S49-S51.
[4] Williams JR, Lorenzo D, Salerno J, et al. Current applications of precision medicine:a bibliometric analysis[J].Per Med,2019,16(4):351-359.
[5] He M, Xia J, Shehab M, et al. The development
of precision medicine in clinical practice[J].Clin Transl Med,2015,4(1):69.
[6] De Maria Marchiano R, Di Sante G, Piro G, et al. Translational research in the era of precision medicine:where we are and where we will go[J].J Pers Med,2021,11(3):216.
[7] Ji Y, Si Y, McMillin GA, et
al. Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine[J].Expert Rev Mol Diagn,2018 ,18(5):411-421.
[8] ICPerMed. ICPerMed 'Family'-Related Initiatives and ERA-Nets[EB/OL].[2023-11-02]. https://www.icpermed.eu/en/related-initiatives.php.
[9] PERMIT. Enhancing
personalised medicine research[EB/OL].[2023-11-02].https://permit-eu.org/.
[10] ICPerMed.Optimizing clinical
research for personalised medicine: recommendations for
funders,regulators and policy makers[EB/OL].[2023-11-02].https://www.icpermed.eu/media/content/ICPerMed_Clinical%20Studies.pdf.
[11] Diaz-Uriarte R, Gómez de Lope E, Giugno R, et al. Ten quick tips
for biomarker discovery and validation analyses using machine learning[J].PLoS Comput Biol,2022,18(8): e1010357.
[12] Fosse V, Oldoni E, Bietrix F, et al. Recommendations for robust and reproducible preclinical
research in personalised medicine[J].BMC Med,2023,21(1),14.
[13] Vicente AM, Ballensiefen W, Jonsson JI. How
personalised medicine will transform healthcare by 2030:the ICPerMed vision[J].J Transl Med,2020,18(1):180.
[14] Swanson K, Wu E, Zhang A, et al. From patterns to
patients:advances in clinical machine learning for
cancer diagnosis, prognosis, and
treatment[J].Cell,2023,186(8):1772-1791.
[15] Desai A, Reddy NK, Subbiah V. Top advances
of the year:Precision oncology[J].Cancer,2023,129(11):1634-1642.
[16] Hoxhaj I, Beccia F, Morsella A, et al. A survey of experts on personalized medicine landscape in
European Union and China[J].BMC Health Serv Res,2023,23(1):517.
[17] Middleton G, Robbins H, Andre F, et al. A state-of-the-art review of stratified medicine in cancer: towards a future precision medicine strategy in cancer[J].Ann Oncol,2022,33(2):143-157.
[18] Elmore LW, Greer SF, Daniels EC, et al. Blueprint for cancer research:Critical
gaps and opportunities[J].CA Cancer J Clin,2021,71(2):107-139.
[19] National Research Council (US) Committee on A Framework for Developing a New
Taxonomy of Disease.Toward precision medicine:building
a knowledge network for biomedical research and a new taxonomy of disease[M].Washington (DC):National Academies Press (US), 2011.
[20] Car J, Sheikh A, Wicks P, et al. Beyond the hype of big data and artificial intelligence:building foundations for knowledge and wisdom[J].BMC Med,2019,17(1):143.
|